Amylyx Pharmaceuticals, Inc. AMLX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s total costs & expenses?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported total costs & expenses of $43.78M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s total costs & expenses changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s total costs & expenses increased by 15.8% year-over-year, from $37.8M to $43.78M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s total costs & expenses?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s total costs & expenses has grown at a -11.8% compound annual growth rate (CAGR), from $223.57M to $153.29M.
- What does total costs & expenses mean?
- This metric aggregates all operating and non-operating costs incurred by the company to support its business activities during a specific period. It includes research and development, selling, general, and administrative expenses, as well as any other operational outflows. Analyzing this figure provides a comprehensive view of the company's total burn rate and operational scale.